Company AP Biosciences Inc

Equities

6945

TW0006945009

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Company contact information

Sector

Sector Bio Therapeutic Drugs

End-of-day quote Taipei Exchange Other stock markets 18:00:00 2024-05-27 EDT			5-day change	1st Jan Change
59.7 ^TWD	-0.83%		-0.83%	+28.11%

03-19	AP Biosciences Inc Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	AP Biosciences Inc Reports Earnings Results for the Half Year Ended June 30, 2023	CI

AP Biosciences Inc is a Taiwan-based company mainly engaged in the research and development of protein drugs and antibody drugs. The Company develops early candidate drugs and preclinical trials, and develops different monoclonal or bispecific antibody drugs for potential targets, mechanisms of action, and disease characteristics through drug design and existing technology platforms. The Company's technology platform and bispecific protein drug research and development projects include IBI302-anti-vascular endothelial growth factor (VEGF) and anti-complement bifunctional recombinant protein, OmniMab fully human antibody library, AP505-PD-L1 x VEGF bispecific antibody, target-directed T cell activation 3T platform (T-cube), AP203-PD-L1 x CD137 fully human bispecific antibody, and others.

Number of employees: 37

Managers	Title	Age	Since
Jeng-Horng Her FOU	Founder	-	13-05-26
Shu Cheng Lin DFI	Director of Finance/CFO	-	22-10-17
Wan Ju Tseng ADM	Chief Administrative Officer	-	22-10-17

Members of the board	Title	Age	Since
Chih Chuan Chen CHM	Chairman	-	23-05-22
Jeng-Horng Her FOU	Founder	-	13-05-26
Shih Ming Lin BRD	Director/Board Member	-	23-05-22
Hui Chun Wang BRD	Director/Board Member	78	23-05-22
Tsung Chih Chiu BRD	Director/Board Member	-	23-05-22
Ming-Tain Lai BRD	Director/Board Member	-	19-06-03
Hui Chin Tseng BRD	Director/Board Member	-	21-06-03

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	64,847,910	35,844,443 ( 55.27 %)	0	55.27 %

AP Biosciences, Inc.

17/F 3 Yuanqu Street

115010, Taipei

http://www.apbioinc.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
AP BIOSCIENCES INC	+28.11%	120M
VERTEX PHARMACEUTICALS INCORPORATED	+9.83%	115B
REGENERON PHARMACEUTICALS, INC.	+10.80%	105B
BIONTECH SE	-10.84%	22.71B
ARGENX SE	+3.87%	21.83B
GENMAB A/S	-10.42%	18.18B
WUXI APPTEC CO., LTD.	-41.92%	16.52B
BEIGENE, LTD.	-15.11%	16.01B
NEUROCRINE BIOSCIENCES, INC.	+6.62%	14.14B
SAREPTA THERAPEUTICS, INC.	+17.53%	10.71B

Bio Therapeutic Drugs